Fubon Securities (HK) analyst: Zhao Chen
Recent series of PRC food safety scandals is a wake-up call for global analytical instrument players to compete in this new frontier, and we consider Techcomp a strong contender, thanks to its strategic acquisition of specialty technologies in Europe and U.S. that takes decades to build.
Richard Lo, CEO of Techcomp, with analysts. NextInsight file photo A Food safety campaign: The setup of China Food and Drug Administration (CFDA) is the central government's structural response to a series of widespread food safety scandals. The government-led investment in food testing capacity should support the analytical instrument market to expand at 7-8% annual pace.
Techcomp is set to gain higher market share in China due to its technology lead.
Professor S. D. Smith, the founder of Edinburgh Instruments, now is Techcomp’s Chief Scientific Officer. Photo: CompanyWe expect a long term shift to its manufacturing on the back of technology advantage to lift its profitability and gradually reduce its reliance on distribution. Geo-political and currency risks to remain: An unstable or deteriorating Sino-Japan relationship has hurt Techcomp in the past given its distribution of Japanese products remains significant.
Techcomp also shows high earning sensitivity to wild fluctuation of Japanese Yen and other Asian currencies. A higher manufacturing contribution will reduce both risks but this takes time.
Our DCF values Techcomp at HK$3.0 per share and we include in our valuation the currency and margin risks already.
|
» Rapid manufacturing expansion could lift GP margin Techcomp will continue to strengthen its core technology in manufacturing after it acquired two valuable assets from Edinburgh and Bruker. As a result, the revenue from the manufacturing segment will see a higher growth rate than that of the distribution segment. The higher GP margin in manufacturing and the higher revenue proportion from manufacturing will help Techcomp lift its overall GP margin. |
Recent story: TECHCOMP attracts 2 big investors, & gets into largest M&A deal to date